These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 20980695)

  • 1. The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells.
    Paulos CM; Carpenito C; Plesa G; Suhoski MM; Varela-Rohena A; Golovina TN; Carroll RG; Riley JL; June CH
    Sci Transl Med; 2010 Oct; 2(55):55ra78. PubMed ID: 20980695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ICOS cooperates with CD28, IL-2, and IFN-gamma and modulates activation of human naïve CD4+ T cells.
    Mesturini R; Nicola S; Chiocchetti A; Bernardone IS; Castelli L; Bensi T; Ferretti M; Comi C; Dong C; Rojo JM; Yagi J; Dianzani U
    Eur J Immunol; 2006 Oct; 36(10):2601-12. PubMed ID: 17013990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase.
    Gigoux M; Shang J; Pak Y; Xu M; Choe J; Mak TW; Suh WK
    Proc Natl Acad Sci U S A; 2009 Dec; 106(48):20371-6. PubMed ID: 19915142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells.
    McAdam AJ; Chang TT; Lumelsky AE; Greenfield EA; Boussiotis VA; Duke-Cohan JS; Chernova T; Malenkovich N; Jabs C; Kuchroo VK; Ling V; Collins M; Sharpe AH; Freeman GJ
    J Immunol; 2000 Nov; 165(9):5035-40. PubMed ID: 11046032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD28 and inducible costimulator (ICOS) signalling can sustain CD154 expression on activated T cells.
    Kaminski DA; Lee BO; Eaton SM; Haynes L; Randall TD
    Immunology; 2009 Jul; 127(3):373-85. PubMed ID: 19191918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes.
    Parry RV; Rumbley CA; Vandenberghe LH; June CH; Riley JL
    J Immunol; 2003 Jul; 171(1):166-74. PubMed ID: 12816995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and TH-17 cells.
    Bauquet AT; Jin H; Paterson AM; Mitsdoerffer M; Ho IC; Sharpe AH; Kuchroo VK
    Nat Immunol; 2009 Feb; 10(2):167-75. PubMed ID: 19098919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICOS-based chimeric antigen receptors program bipolar TH17/TH1 cells.
    Guedan S; Chen X; Madar A; Carpenito C; McGettigan SE; Frigault MJ; Lee J; Posey AD; Scholler J; Scholler N; Bonneau R; June CH
    Blood; 2014 Aug; 124(7):1070-80. PubMed ID: 24986688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD28 related molecule ICOS: T cell modulation in the presence and absence of B7.1/2 and regulational expression in multiple sclerosis.
    Wiendl H; Neuhaus O; Mehling M; Wintterle S; Schreiner B; Mitsdoerffer M; Wienhold W; Weissert R; Wessels J; Hartung HP; Weller M; Tolosa E; Melms A
    J Neuroimmunol; 2003 Jul; 140(1-2):177-87. PubMed ID: 12864987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible costimulator protein controls the protective T cell response against Listeria monocytogenes.
    Mittrücker HW; Kursar M; Köhler A; Yanagihara D; Yoshinaga SK; Kaufmann SH
    J Immunol; 2002 Nov; 169(10):5813-7. PubMed ID: 12421962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICOS and CD28 reversely regulate IL-10 on re-activation of human effector T cells with mature dendritic cells.
    Witsch EJ; Peiser M; Hutloff A; Büchner K; Dorner BG; Jonuleit H; Mages HW; Kroczek RA
    Eur J Immunol; 2002 Sep; 32(9):2680-6. PubMed ID: 12207353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of CD28, CTLA4, and inducible costimulator in acute graft-versus-host disease in mice.
    Li J; Semple K; Suh WK; Liu C; Chen F; Blazar BR; Yu XZ
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):962-9. PubMed ID: 21447398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inducible costimulator augments Tc17 cell responses to self and tumor tissue.
    Nelson MH; Kundimi S; Bowers JS; Rogers CE; Huff LW; Schwartz KM; Thyagarajan K; Little EC; Mehrotra S; Cole DJ; Rubinstein MP; Paulos CM
    J Immunol; 2015 Feb; 194(4):1737-47. PubMed ID: 25576595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducible Costimulator Expressing T Cells Promote Parasitic Growth During Blood Stage
    Jogdand GM; Sengupta S; Bhattacharya G; Singh SK; Barik PK; Devadas S
    Front Immunol; 2018; 9():1041. PubMed ID: 29892278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICOS-mediated costimulation on Th2 differentiation is achieved by the enhancement of IL-4 receptor-mediated signaling.
    Watanabe M; Watanabe S; Hara Y; Harada Y; Kubo M; Tanabe K; Toma H; Abe R
    J Immunol; 2005 Feb; 174(4):1989-96. PubMed ID: 15699127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eminent role of ICOS costimulation for T cells interacting with plasmacytoid dendritic cells.
    Janke M; Witsch EJ; Mages HW; Hutloff A; Kroczek RA
    Immunology; 2006 Jul; 118(3):353-60. PubMed ID: 16827896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
    Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
    Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for inducible costimulator protein in the CD28- independent mechanism of resistance to Toxoplasma gondii.
    Villegas EN; Lieberman LA; Mason N; Blass SL; Zediak VP; Peach R; Horan T; Yoshinaga S; Hunter CA
    J Immunol; 2002 Jul; 169(2):937-43. PubMed ID: 12097399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of resting human primary T cells with chimeric receptors: costimulation from CD28, inducible costimulator, CD134, and CD137 in series with signals from the TCR zeta chain.
    Finney HM; Akbar AN; Lawson AD
    J Immunol; 2004 Jan; 172(1):104-13. PubMed ID: 14688315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A co-stimulatory molecule on activated T cells, H4/ICOS, delivers specific signals in T(h) cells and regulates their responses.
    Arimura Y; Kato H; Dianzani U; Okamoto T; Kamekura S; Buonfiglio D; Miyoshi-Akiyama T; Uchiyama T; Yagi J
    Int Immunol; 2002 Jun; 14(6):555-66. PubMed ID: 12039907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.